Focus: Empatica is a biotechnology company headquartered in Milan, Italy, specializing in seizure detection and wearable medical devices for neurology applications. The company focuses on innovative remote monitoring technologies rather than traditional small-molecule or biologic pharmaceuticals.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Growing — net +9 jobs in 30d
9 jobs added vs 0 removed. Steady team buildout.
Empatica represents a high-risk, early-stage medtech opportunity suitable for mission-driven professionals willing to bet on wearable seizure detection but facing significant execution and funding uncertainties.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Empatica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Empatica's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles